Pathobiology of ALK+ anaplastic large-cell lymphoma
Top Cited Papers
Open Access
- 1 October 2007
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 110 (7) , 2259-2267
- https://doi.org/10.1182/blood-2007-04-060715
Abstract
Anaplastic large-cell lymphoma (ALCL) was initially recognized on the basis of morphologic features and the consistent expression of CD30. It then became evidenKeywords
This publication has 148 references indexed in Scilit:
- Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALKProceedings of the National Academy of Sciences, 2007
- Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genesJournal of Clinical Investigation, 2006
- Identification of multiple SNT-binding sites on NPM-ALK oncoprotein and their involvement in cell transformationOncogene, 2006
- The Expression of CD30 in Anaplastic Large Cell Lymphoma Is Regulated by Nucleophosmin-Anaplastic Lymphoma Kinase–Mediated JunB Level in a Cell Type–Specific MannerCancer Research, 2006
- Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3Proceedings of the National Academy of Sciences, 2006
- NIPA Defines an SCF-Type Mammalian E3 Ligase that Regulates Mitotic EntryCell, 2005
- Activation and Inhibition of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase by Monoclonal Antibodies and Absence of Agonist Activity of PleiotrophinJournal of Biological Chemistry, 2005
- Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicityBlood, 2003
- Design and Evaluation of Chemically Synthesized siRNA Targeting the NPM-ALK Fusion Site in Anaplastic Large Cell Lymphoma (ALCL)Oligonucleotides, 2003
- Chromosome 5q35 Breakpoint in Malignant HistiocytosisNew England Journal of Medicine, 1986